Evidence map›Paper›PMID 21150443›Full record

ReviewCurrent opinion in pediatrics2011

Future applications of antioxidants in premature infants.

Jennifer W Lee, Jonathan M Davis

Open access · greenAbstract readReview
In one paragraph

Review in Current opinion in pediatrics, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed, 2 pooled it
9.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

65 citing papers in PubMed, 2 syntheses or guidelines pooled it, 162 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Congenital heart disease-associated pulmonary dysplasia and its underlying mechanisms.American journal of physiology. Lung cellular and molecular physiology · 2023
    Article
  14. Review
  15. Review
  16. Article
  17. Nutrition Support Practices for Infants Born <750 Grams or <25 Weeks Gestation: A Call for More Research.International journal of environmental research and public health · 2022
    Article
  18. Review
  19. Review
  20. Article

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Jennifer W LeeThe Floating Hospital for Children at Tufts Medical Center, Tufts University School of Medicine, Boston, Massachusetts 02111, USA.
Jonathan M Davis
Tufts Medical Center · USTufts University · US

Funding

DELIVERY OF ANTIOXIDANT ENZYMES &GENES TO NEONATAL LUNGR01HL064158 · NHLBI · WINTHROP-UNIVERSITY HOSPITAL · PI DAVIS, JONATHAN M. · 2000 to 2004
$2.2M
Establishing Risk in Neonatal Abstinence SyndromeR21DA041706 · NIDA · TUFTS MEDICAL CENTER · PI DAVIS, JONATHAN M., LESTER, BARRY M. · 2016 to 2017
$524k
NHLBI NIH HHS R01 HL064158NIDA NIH HHS R21 DA041706
6 · The paper itself

Abstract

purpose of reviewThis review will examine the unique susceptibility of premature infants to oxidative stress, the role of reactive oxygen species (ROS) in the pathogenesis of common disorders of the preterm infant, and potential for therapeutic interventions using enzymatic and/or nonenzymatic antioxidants. RECENT

findingsOxidative stress is caused by an imbalance between the production of ROS and the ability to detoxify them with the help of antioxidants. The premature infant is especially susceptible to ROS-induced damage because of inadequate antioxidant stores at birth, as well as impaired upregulation in response to oxidant stress. Thus, the premature infant is at increased risk for the development of ROS-induced diseases of the newborn, such as bronchopulmonary dysplasia, retinopathy of prematurity, necrotizing enterocolitis, and periventricular leukomalacia. SUMMARY: Potential therapies for ROS-induced disease include both enzymatic and nonenzymatic antioxidant preparations. More research is required to determine the beneficial effects of supplemental antioxidant therapy.

Indexed as

AntioxidantsFemaleHumansInfant, NewbornInfant, PrematureInfant, Premature, DiseasesOxidative StressPregnancyPregnancy ComplicationsPregnancy OutcomePremature BirthReactive Oxygen SpeciesAntioxidantsReactive Oxygen Species

Identifiers

PMID21150443
PMCPMC3289059
OpenAlexW2030119563

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.